Matches in SemOpenAlex for { <https://semopenalex.org/work/W2805151159> ?p ?o ?g. }
- W2805151159 abstract "Natural Killer cells (NK) contribute significantly to eradication of cancer cells and there is increased interest in strategies to enhance it’s efficacy.Therapeutic agents used in the treatment of cancer can impact the immune system in a quantitative and qualitative manner. In this study we evaluated the impact of arsenic trioxide (ATO) used in the management of acute promyelocytic leukemia (APL) on NK cell reconstitution and function. In patients with APL treated with single agent ATO, there was a significant delay in the reconstitution of circulating NK cells to reach median normal levels from the time of diagnosis (655 days for NK cells vs 145 and 265 days for T cells and B cells respectively). In-vitro experiments demonstrated that ATO significantly reduced the CD34 hematopoietic stem cell (HSC) differentiation to NK cells. Additional experimental data demonstrate that CD34+ sorted cells when exposed to ATO lead to a significant decrease in the expression of IKZF2, ETS1 and TOX transcription factors involved in NK cell differentiation and maturation. In contrast, exposure of NK cells and leukemic cells to low doses of ATO modulates NK cell receptors and malignant cell ligand profile in a direction that enhances NK cell mediated cytolytic activity. We have demonstrated that NK cytolytic activity towards NB4 cell line when exposed to ATO was significantly higher when compared with controls. We also validated this beneficial effect in a mouse model of APL were the median survival with ATO alone and ATO+ NK was 44 days (range:33-46) vs 54 days (range:52-75). In conclusion ATO has a differential quantitative and qualitative effect on NK cell activity. This information can potentially be exploited in the management of leukemia." @default.
- W2805151159 created "2018-06-13" @default.
- W2805151159 creator A5002377138 @default.
- W2805151159 creator A5004998915 @default.
- W2805151159 creator A5007766423 @default.
- W2805151159 creator A5008677291 @default.
- W2805151159 creator A5010440962 @default.
- W2805151159 creator A5013898922 @default.
- W2805151159 creator A5018632343 @default.
- W2805151159 creator A5018836410 @default.
- W2805151159 creator A5028328158 @default.
- W2805151159 creator A5032393853 @default.
- W2805151159 creator A5037454036 @default.
- W2805151159 creator A5040889704 @default.
- W2805151159 creator A5049834304 @default.
- W2805151159 creator A5060881310 @default.
- W2805151159 creator A5072266288 @default.
- W2805151159 creator A5072793484 @default.
- W2805151159 creator A5073620732 @default.
- W2805151159 creator A5073957041 @default.
- W2805151159 date "2018-06-14" @default.
- W2805151159 modified "2023-09-29" @default.
- W2805151159 title "Arsenic Trioxide Enhances the NK Cell Cytotoxicity Against Acute Promyelocytic Leukemia While Simultaneously Inhibiting Its Bio-Genesis" @default.
- W2805151159 cites W1498134845 @default.
- W2805151159 cites W1599718730 @default.
- W2805151159 cites W1780868497 @default.
- W2805151159 cites W192794212 @default.
- W2805151159 cites W1966452132 @default.
- W2805151159 cites W1968708123 @default.
- W2805151159 cites W1972494701 @default.
- W2805151159 cites W1980021547 @default.
- W2805151159 cites W1989435822 @default.
- W2805151159 cites W1993565885 @default.
- W2805151159 cites W2003474867 @default.
- W2805151159 cites W2022069273 @default.
- W2805151159 cites W2023653499 @default.
- W2805151159 cites W2029928472 @default.
- W2805151159 cites W2030499746 @default.
- W2805151159 cites W2030702295 @default.
- W2805151159 cites W2034751554 @default.
- W2805151159 cites W2035499322 @default.
- W2805151159 cites W2035895885 @default.
- W2805151159 cites W2036043979 @default.
- W2805151159 cites W2037972042 @default.
- W2805151159 cites W2047902191 @default.
- W2805151159 cites W2057398639 @default.
- W2805151159 cites W2064008845 @default.
- W2805151159 cites W2066402057 @default.
- W2805151159 cites W2067125030 @default.
- W2805151159 cites W2079152313 @default.
- W2805151159 cites W2079526924 @default.
- W2805151159 cites W2100010067 @default.
- W2805151159 cites W2104222293 @default.
- W2805151159 cites W2108395794 @default.
- W2805151159 cites W2112171779 @default.
- W2805151159 cites W2112595887 @default.
- W2805151159 cites W2119810076 @default.
- W2805151159 cites W2124910438 @default.
- W2805151159 cites W2127334297 @default.
- W2805151159 cites W2130158187 @default.
- W2805151159 cites W2133432107 @default.
- W2805151159 cites W2138600064 @default.
- W2805151159 cites W2142378149 @default.
- W2805151159 cites W2144318755 @default.
- W2805151159 cites W2147271210 @default.
- W2805151159 cites W2165813814 @default.
- W2805151159 cites W2170325085 @default.
- W2805151159 cites W2521461373 @default.
- W2805151159 doi "https://doi.org/10.3389/fimmu.2018.01357" @default.
- W2805151159 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6010577" @default.
- W2805151159 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29963052" @default.
- W2805151159 hasPublicationYear "2018" @default.
- W2805151159 type Work @default.
- W2805151159 sameAs 2805151159 @default.
- W2805151159 citedByCount "14" @default.
- W2805151159 countsByYear W28051511592019 @default.
- W2805151159 countsByYear W28051511592020 @default.
- W2805151159 countsByYear W28051511592021 @default.
- W2805151159 countsByYear W28051511592022 @default.
- W2805151159 countsByYear W28051511592023 @default.
- W2805151159 crossrefType "journal-article" @default.
- W2805151159 hasAuthorship W2805151159A5002377138 @default.
- W2805151159 hasAuthorship W2805151159A5004998915 @default.
- W2805151159 hasAuthorship W2805151159A5007766423 @default.
- W2805151159 hasAuthorship W2805151159A5008677291 @default.
- W2805151159 hasAuthorship W2805151159A5010440962 @default.
- W2805151159 hasAuthorship W2805151159A5013898922 @default.
- W2805151159 hasAuthorship W2805151159A5018632343 @default.
- W2805151159 hasAuthorship W2805151159A5018836410 @default.
- W2805151159 hasAuthorship W2805151159A5028328158 @default.
- W2805151159 hasAuthorship W2805151159A5032393853 @default.
- W2805151159 hasAuthorship W2805151159A5037454036 @default.
- W2805151159 hasAuthorship W2805151159A5040889704 @default.
- W2805151159 hasAuthorship W2805151159A5049834304 @default.
- W2805151159 hasAuthorship W2805151159A5060881310 @default.
- W2805151159 hasAuthorship W2805151159A5072266288 @default.
- W2805151159 hasAuthorship W2805151159A5072793484 @default.
- W2805151159 hasAuthorship W2805151159A5073620732 @default.
- W2805151159 hasAuthorship W2805151159A5073957041 @default.
- W2805151159 hasBestOaLocation W28051511591 @default.